Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandi N Sheth

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Journal of Women'S Health (2002)|January 8, 2019
Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. WomenJenna S Hynes, Anandi N Sheth, Eva Lathrop, et al.
Implementation Science Communications|June 9, 2023
Using qualitative comparative analysis to understand the conditions that produce successful PrEP implementation in family planning clinicsKaitlin N Piper, Katherine M Anderson, Caroline W Kokubun, et al.
Journal of Experimental Pharmacology|May 18, 2016
Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptivesAmanda Marie James, Jennifer R King, Ighovwerha Ofotokun, et al.
Sexually Transmitted Diseases|December 2, 2020
Who Is Practicing Expedited Partner Therapy and Why? Insights From Providers Working in Specialties With High Volumes of Sexually Transmitted InfectionsMegan McCool-Myers, Peggy Goedken, Megan C Henn, et al.
Contraception|October 23, 2017
Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United StatesJenna S Hynes, Jessica M Sales, Anandi N Sheth, et al.
BMC Pharmacology & Toxicology|May 25, 2019
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort studyWorkineh Shibeshi, Anandi N Sheth, Addisu Admasu, et al.
Frontiers in Medicine|March 6, 2026
Editorial: Advancing HIV treatment and prevention for cisgender women: approaches to optimize health outcomesMaria L Alcaide, Renee Heffron, Seble G Kassaye, et al.
Contraception|November 15, 2020
Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011Anandi N Sheth, Christine D Angert, Lisa B Haddad, et al.
Contraception|February 4, 2019
Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, GeorgiaJessica M Sales, Ashley L Phillips, Ilyssa Tamler, et al.
AIDS Care|December 20, 2017
Long term engagement in HIV care among postpartum women with perinatal HIV infection in the United StatesChristina M Meade, Sophia A Hussen, Florence Momplaisir, et al.
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Journal of Women'S Health (2002)|January 8, 2019
Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. WomenJenna S Hynes, Anandi N Sheth, Eva Lathrop, et al.
Implementation Science Communications|June 9, 2023
Using qualitative comparative analysis to understand the conditions that produce successful PrEP implementation in family planning clinicsKaitlin N Piper, Katherine M Anderson, Caroline W Kokubun, et al.
Journal of Experimental Pharmacology|May 18, 2016
Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptivesAmanda Marie James, Jennifer R King, Ighovwerha Ofotokun, et al.
Sexually Transmitted Diseases|December 2, 2020
Who Is Practicing Expedited Partner Therapy and Why? Insights From Providers Working in Specialties With High Volumes of Sexually Transmitted InfectionsMegan McCool-Myers, Peggy Goedken, Megan C Henn, et al.
Contraception|October 23, 2017
Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United StatesJenna S Hynes, Jessica M Sales, Anandi N Sheth, et al.
BMC Pharmacology & Toxicology|May 25, 2019
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort studyWorkineh Shibeshi, Anandi N Sheth, Addisu Admasu, et al.
Frontiers in Medicine|March 6, 2026
Editorial: Advancing HIV treatment and prevention for cisgender women: approaches to optimize health outcomesMaria L Alcaide, Renee Heffron, Seble G Kassaye, et al.
Contraception|November 15, 2020
Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011Anandi N Sheth, Christine D Angert, Lisa B Haddad, et al.
Contraception|February 4, 2019
Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, GeorgiaJessica M Sales, Ashley L Phillips, Ilyssa Tamler, et al.
AIDS Care|December 20, 2017
Long term engagement in HIV care among postpartum women with perinatal HIV infection in the United StatesChristina M Meade, Sophia A Hussen, Florence Momplaisir, et al.
Pageof 16